Início › Câncer de Ovário › Virgínia › Arlington
Ensaios clínicos de Câncer de Ovário em Arlington, VA
46 estudos para Câncer de Ovário estão buscando participantes em locais em Arlington e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- Inova Fair Oaks Hospital, Fairfax · a 11 mi de distância
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- Inova Fairfax Hospital, Falls Church · a 4 mi de distância
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RecrutandoFase 1/2
- Research Site, Fairfax · a 11 mi de distância
A Study of PHST001 in Advanced Solid Tumors
RecrutandoFase 1
- NEXT Oncology - Virginia, Fairfax · a 11 mi de distância
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- NEXT Virginia, Fairfax · a 11 mi de distância
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RecrutandoFase 2
- Next Virginia /ID# 279684, Fairfax · a 11 mi de distância
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RecrutandoFase 1
- Site 04, Fairfax · a 11 mi de distância
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
RecrutandoFase 1
- Next Virginia /ID# 278607, Fairfax · a 11 mi de distância
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RecrutandoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecrutandoFase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · a 11 mi de distância
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
RecrutandoFase 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
Study of AVZO-021 in Patients With Advanced Solid Tumors
RecrutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · a 11 mi de distância
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecrutandoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
RecrutandoFase 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · a 11 mi de distância
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecrutandoFase 1/2
- NEXT Oncology, Fairfax · a 11 mi de distância
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecrutandoFase 3
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecrutandoFase 2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
RecrutandoFase 1/2
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- Next Oncology Virginia, Fairfax · a 11 mi de distância
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecrutandoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
RecrutandoFase 1
- NEXT Oncology, Fairfax · a 11 mi de distância
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RecrutandoFase 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · a 11 mi de distância
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RecrutandoFase 1
- Inova Schar Cancer Institute, Falls Church · a 4 mi de distância
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RecrutandoFase 1
- Normunity Investigational Site, Fairfax · a 11 mi de distância
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recrutando
- Inova Fairfax Hospital, Falls Church · a 4 mi de distância
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- Inova Fair Oaks Hospital, Fairfax · a 11 mi de distância
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- Clinical Trial Site, Fairfax · a 11 mi de distância
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RecrutandoFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecrutandoFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RecrutandoFase 2
- 522, Fairfax · a 11 mi de distância
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · a 11 mi de distância
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecrutandoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RecrutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- NEXT, Fairfax · a 11 mi de distância
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RecrutandoFase 3
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RecrutandoFase 1
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
RecrutandoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
RecrutandoFase 1
- NEXT Oncology, Fairfax · a 11 mi de distância
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RecrutandoFase 1
- Dren Investigational Site, Fairfax · a 11 mi de distância
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
RecrutandoFase 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Ensaios de Câncer de Ovário em outras cidades
- Houston, TX89 estudos
- New York City, NY69 estudos
- Boston, MA61 estudos
- Los Angeles, CA50 estudos
- Nashville, TN49 estudos
- Philadelphia, PA44 estudos
- Columbus, OH39 estudos
- St. Louis, MO38 estudos
- Chicago, IL36 estudos
- San Antonio, TX31 estudos
- Cleveland, OH30 estudos
- Pittsburgh, PA30 estudos
Outros estudos em Arlington
- Câncer de Pulmão de Não Pequenas Células104 estudos
- Câncer Metastático53 estudos
- Câncer Colorretal52 estudos
- Câncer (todos os tipos)48 estudos
- Câncer de Mama47 estudos
- Câncer de Pulmão41 estudos
- Câncer Endometrial39 estudos
- Câncer de Pâncreas33 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço26 estudos
- Câncer de Pulmão de Células Pequenas23 estudos
- Câncer de Estômago20 estudos
- Câncer de Mama Triplo-Negativo20 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.